Position in RCKT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,079,902
-$2,849,588 QoQ
Shares Held
315,761
-71.2% QoQ
Ownership
0.288%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 180 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in RCKT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. RCKT ranks #201 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in RCKT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,079,902 | 315,761 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,929,490 | 1,097,623 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,483,070 | 2,131,929 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,247,563 | 1,609,682 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,227,132 | 1,725,360 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $517,154 | 41,142 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $402,941 | 21,816 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $497,149 | 23,091 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,041,215 | 150,008 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,639,832 | 254,916 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,120,986 | 396,339 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $876,267 | 44,100 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,505,759 | 146,279 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,408,061 | 71,950 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,410,424 | 338,999 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,012,917 | 218,962 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,880,149 | 244,650 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,416,328 | 248,114 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,213,383 | 207,875 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,465,921 | 168,569 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $14,699,159 | 331,286 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,674,843 | 103,480 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $331,630 | 14,507 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $481,096 | 22,986 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||